Mantovani A, Gray P A, Van Damme J, Sozzani S
Istituto di Ricerche Farmacologiche Mario Negri, Milan, Italy.
J Leukoc Biol. 2000 Sep;68(3):400-4.
Macrophage-derived chemokine (MDC) is a CC chemokine paradigmatic of emerging aspects of chemokine immunobiology. It is constitutively expressed, yet microbial products and cytokines regulate its expression with divergent effects of type II (IL-4 and IL-13) and type I (interferon) cytokines. Processing of the mature protein by dipeptidyl peptidase IV/CD26 provides a further level of regulation. It acts on diverse cellular targets including dendritic cells (DC), NK cells, and T cell subsets. Among these, MDC is a potent attractant for CCR4 expressing polarized Th2 and Tc2 cells, and evidence is consistent with a role of this chemokine as an amplification loop of polarized type II responses. Emerging indications on the involvement of MDC in diverse pathologies, ranging from allergic reactions to HIV infection and neoplasia, are discussed.
巨噬细胞衍生趋化因子(MDC)是趋化因子免疫生物学新出现方面的典型CC趋化因子。它组成性表达,但微生物产物和细胞因子会以II型(IL-4和IL-13)和I型(干扰素)细胞因子的不同作用来调节其表达。二肽基肽酶IV/CD26对成熟蛋白的加工提供了进一步的调节水平。它作用于多种细胞靶点,包括树突状细胞(DC)、自然杀伤细胞和T细胞亚群。其中,MDC是表达CCR4的极化Th2和Tc2细胞的有效趋化剂,并且有证据表明这种趋化因子作为极化II型反应的放大环发挥作用。本文讨论了MDC参与从过敏反应到HIV感染和肿瘤形成等多种病理过程的新迹象。